Evidence map›Paper›PMID 39504346›Full record

ArticleRevista medica del Instituto Mexicano del Seguro Social2024

[Pulmonary Hypertension Centers].

Luis Efren Santos-Martínez

Abstract readEditorialEnglish Abstract
In one paragraph

Article in Revista medica del Instituto Mexicano del Seguro Social, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Luis Efren Santos-MartínezInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Cardiología, Servicio de Hipertensión Pulmonar y Corazón Derecho. Ciudad de México, México.ORCID 0000-0002-2866-3047

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pulmonary hypertension is a group of entities whose most severe form is represented by pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Patient survival is reduced without treatment, so early diagnosis and treatment should be the primary objective. The Instituto Mexicano del Seguro Social participates in this fight to improve the care of these patients, since it has doctors with knowledge in the entity and even a department of Pulmonary Hypertension and Right Heart from where a successful, viable and versatile structure proposal has been made. Time has shown that this may not be enough and that, due to the size of the national territory for effective medical coverage, the time for care may be prolonged. For this reason, other similar departments would be required within the highly specialized units of the institution.

Indexed as

Hypertension, PulmonaryAcademies and InstitutesHumansMexicoSocial SecurityDelivery of Health CarePractice GuidelinePulmonary CirculationPulmonary Hypertension

Identifiers

PMID39504346
PMCPMC12129564

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.